Inhibikase Therapeutics, Inc. (IKT) Operating margin 2020–2023
Inhibikase Therapeutics, Inc. (IKT) operating margin by fiscal year — reported operating income divided by reported revenue.
-7712.0%FY2023 · since FY2020: -403.5% → -7712.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -7712.0% | +6974.2 pp |
| FY2022 | -14686.2% | -14209.9 pp |
| FY2021 | -476.2% | -72.7 pp |
| FY2020 | -403.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice